(Q45262603)

English

Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen

scientific article published on 3 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

4

object named as

Lorne A Babiuk

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1

object named as

George Mutwiri

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Ponn Benjamin

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Henry Soita

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

3 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

2680-2688

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Recent developments in adjuvants for vaccines against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

The instructive role of innate immunity in the acquired immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix?)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Mechanisms of stimulation of the immune response by aluminum adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Molecular mechanisms regulating Th1 immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Cytokines as adjuvants for the induction of mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Germline transcripts of the murine immunoglobulin gamma 2a gene: structure and induction by IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.031

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.03.031

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45262603&oldid=2071887469"